-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 RtxQ6QjnEyAmtr90xEhS7ejpWN2ntDwcFAU8FiRSxYL15Odil7J02V80Wbbh/5JZ
 XprFjMmldOtLCOKg045HPQ==

<SEC-DOCUMENT>0000719135-96-000010.txt : 19960816
<SEC-HEADER>0000719135-96-000010.hdr.sgml : 19960816
ACCESSION NUMBER:		0000719135-96-000010
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	19950630
FILED AS OF DATE:		19960815
SROS:			AMEX

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AN CON GENETICS INC
		CENTRAL INDEX KEY:			0000719135
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				112644611
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-12183
		FILM NUMBER:		96616451

	BUSINESS ADDRESS:	
		STREET 1:		ONE HUNTINGTON QUADRANGLE
		STREET 2:		STE 1N11
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		5166948470

	MAIL ADDRESS:	
		STREET 1:		ONE HUNTINGTON QUADDRANGLE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<TEXT>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-27
<SEQUENCE>2
<FLAWED>
<TEXT>
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>




     







AN-CON GENETICS, INC.
APPENDIX A TO ITEM 601(c) OF REGULATION S-B
COMMERCIAL AND INDUSTRIAL COMPANIES
ARTICLE 5 OF REGULATION S-X
FINANCIAL DATA SCHEDULE FOR THE SIX
MONTHS ENDED JUNE 30, 1996



<PAGE>

EXHIBIT 27
AN-CON GENETICS, INC.
APPENDIX A TO ITEM 601(c) OF REGULATION S-B
COMMERCIAL AND INDUSTRIAL COMPANIES
ARTICLE 5 OF REGULATION S-X
FINANCIAL DATA SCHEDULE FOR THE SIX
MONTHS JUNE 30, 1996
                                                                 
                         
                                                            
                                                                 June 30,
ITEM NUMBER      ITEM DESCRIPTION                     1996
                                              
5-02 (1)       Cash and cash items                    75,400
5-02 (2)       Marketable securities                      --
5-02 (3) (a) (1)                                            Notes and accounts
               receivable-trade                      581,700
5-02 (4)       Allowances for doubtful accounts           --    
5-02 (6)       Inventory                          727,400
5-02 (9)       Total current assets                1,512,000
5-02 (13)      Property, plant and equipment       2,243,100
5-02 (14)      Accumulated depreciation              813,300
5-02 (18)      Total assets                        3,688,900
5-02 (21)      Total current liabilities           2,541,800
5-02 (22)      Bonds, mortgages and similar debt     698,300
5-02 (28)      Preferred stock-mandatory redemption       --
5-02 (29)      Preferred stock-no mandatory redemption    --
5-02 (30)      Common stock                           66,500
5-02 (31)      Other stockholders' equity            655,400
5-02 (32)      Total liabilities and stockholders' equity3,688,900
5-03 (b) (a)   Net sales of tangible products      3,214,200
5-03 (b) 1     Total revenues                      3,214,200
5-03 (b) 2 (a) Cost of tangible goods sold         1,599,600
5-03 (b) 2     Total costs and expenses applicable to 
                sales and revenue                  1,599,600
5-03 (b) 3     Other costs and expenses            1,309,500
5-03 (b) 5     Provision for doubtful accounts and notes  --
5-03 (b) (8)   Interest and amortization of debt discount  64,500
5-03 (b) (10)  Income before taxes and other items( 240,600)
5-03 (b) (11)  Income tax expense                     84,200
5-03 (b) (14)  Income/loss continuing operations     156,400
5-03 (b) (15)  Discontinued operations                    --
5-03 (b) (17)  Extraordinary items                        --
5-03 (b) (18)  Cumulative effect-changes in accounting 
                principles                                --
5-03 (b) (19)  Net income or loss                    156,400
5-03 (b) (20)  Earnings per share - primary             .02
5-03 (b) (20)  Earnings per share - fully diluted       .02





</TABLE>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
